, Fucose, placental evolution and the glycocode, vol.22, p.211, 2012.
Estimation of 213 fetal weight with the use of head, body and femur measurements-a prospective 214 study, Am. J Obstet. Gynecol, vol.151, pp.333-340, 1985. ,
Maternal Fetal Medicine Committee, Intrauterine 216 growth restriction: screening, diagnosis and management, J Obstet. Gynaecol ,
, Can, vol.35, pp.741-57, 2013.
, American College of Obstetricians and Gynecologists, ACOG Practice bulletin 219 no. 134: fetal growth restriction, Obstet. Gynecol, vol.121, pp.1122-1155, 2013.
Update on the Diagnosis and Classification of Fetal 221 ,
, Growth Restriction and Proposal of a Stage-Based Management Protocol, Fetal 222 Diagn. Ther, vol.36, pp.86-98, 2014.
Validating 224 the weight gain of preterm infants between the reference growth curve of the 225 fetus and the term infant, BMC Pediatr, vol.13, p.227, 2013. ,
Tissue Microarrays: Construction and Uses, Methods in 228 molecular biology, vol.724, pp.23-35, 2011. ,
, , p.230
Le Highlights ? Placental endothelial glycocalyx fucosylation was studied in terminal and stem villi ,
, ? Fucosylated type 2 glycans changes may reflect alterations of villi in FGR
FGR differs from LO-FGR by a markedly increased Le Y expression ,
, ? Expression patterns of fucosylated glycans may reflect placental glycopathology in FGR